The quality management system of the biotechnology company complies with the European in-vitro Diagnostic Regulation (IVDR)
Quality orientation is an integral part of the culture and processes at R-Biopharm AG. The biotechnology company from southern Hesse thus ensures that quality is integrated throughout the entire company and continually improved in order to deliver reliable products for the health of patients in the long term. The family owned company has regular audits conducted to check the suitability and functionality of all quality-related elements. In fall 2021, R-Biopharm was one of the first companies to undergo the comprehensive audit for the new IVDR certification by TÜV SÜD and has now received the certificate.
Comunicat de presă furnizat şi asumat de APA OTS
Citeşte comunicatul în întregime la adresa http://www.comunicate.mediafax.biz/Pages/Public/Comunicate.aspx?comunicatId=16428